enVVeno Medical (NVNO)
NASDAQ:NVNO
Total Valuation
enVVeno Medical has a market cap or net worth of $7.18M. The enterprise value is -$2.18M.
Market Cap$7.18M
Enterprise Value-$2.18M
Share Statistics
enVVeno Medical has 655,521 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding655,521
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
enVVeno Medical’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -75.10%.
Return on Equity (ROE)-0.72
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-75.10%
Return on Capital Employed (ROCE)-0.76
Revenue Per Employee0.00
Profits Per Employee-526.27K
Employee Count37
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of enVVeno Medical is ―. enVVeno Medical’s PEG ratio is 0.00352.
PE Ratio―
PS Ratio0.00
PB Ratio0.25
Price to Fair Value0.25
Price to FCF-0.43
Price to Operating Cash Flow-0.39
PEG Ratio0.00352
Income Statement
In the last 12 months, enVVeno Medical had revenue of 0.00 and earned -19.47M in profits. Earnings per share was -33.06.
Revenue0.00
Gross Profit-489.00K
Operating Income-20.90M
Pretax Income-19.47M
Net Income-19.47M
EBITDA-20.41M
Earnings Per Share (EPS)-33.06
Cash Flow
In the last 12 months, operating cash flow was -15.57M and capital expenditures -15.00K, giving a free cash flow of -15.57M billion.
Operating Cash Flow-15.57M
Free Cash Flow-15.57M
Free Cash Flow per Share-23.76
Dividends & Yields
enVVeno Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.80
52-Week Price Change-86.40%
50-Day Moving Average10.59
200-Day Moving Average47.48
Relative Strength Index (RSI)45.79
Average Volume (3m)589.93K
Important Dates
enVVeno Medical upcoming earnings date is May 4, 2026, Before Open (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateMay 4, 2026
Ex-Dividend Date―
Financial Position
enVVeno Medical as a current ratio of 13.58, with Debt / Equity ratio of 2.58%
Current Ratio13.58
Quick Ratio13.58
Debt to Market Cap0.06
Net Debt to EBITDA0.12
Interest Coverage Ratio0.00
Taxes
In the past 12 months, enVVeno Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
enVVeno Medical EV to EBITDA ratio is -0.21, with an EV/FCF ratio of -0.28.
EV to Sales0.00
EV to EBITDA-0.21
EV to Free Cash Flow-0.28
EV to Operating Cash Flow-0.28
Balance Sheet
enVVeno Medical has $28.21M in cash and marketable securities with $700.00K in debt, giving a net cash position of $27.51M billion.
Cash & Marketable Securities$28.21M
Total Debt$700.00K
Net Cash$27.51M
Net Cash Per Share$41.97
Tangible Book Value Per Share$46.06
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for enVVeno Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast18.94%